Results 111 to 115 of about 10,542 (115)

t(11;14) multiple myeloma patient: minimal residual disease after 10 years of follow-up - a case report. [PDF]

Haematologica
Decheiver S, Schavgoulidze A, Maheo S, Vion PA, Lucidarme O, Corre J, Garderet L.   +6 more
europepmc   +1 more source

Outcome of Metastatic Biliary Tract Cancer Harbouring <i>IDH1</i> or <i>FGFR2</i> Alterations: A Retrospective Observational Real-World Study from a French Cohort. [PDF]

J Clin Med
Barbe-Richaud JB, Moinard-Butot F, Cotton M, Bigot C, Rivière P, Belletier C, Pencreach E, Karouby D, Chiappa P, Eberst L, Kurtz JE, Ben Abdelghani M.   +11 more
europepmc   +1 more source

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas. [PDF]

ESMO Open
Filippini DM, Cabarrou B, Dupain C, Halladjian M, Coquan E, Sablin MP, Mazzarella L, Francisco M, Servant N, Tonini MM, Hundt AF, Castel-Ajgal Z, You B, Bigot F, Ghiringhelli F, Vansteene D, Gomez-Roca C, Cousin S, Lambert A, Saada-Bouzid E, Durando X, Abdeddaim C, Borel C, Chaltiel R, Borcoman E, Legrand F, Bernhart S, Jimenez M, Bièche I, Filleron T, Le Tourneau C, Kamal M, Jeannot E.   +32 more
europepmc   +1 more source

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE. [PDF]

ESMO Open
Fayette J, Cropet C, Toullec C, Burgy M, Bruyas A, Sire C, Lagrange A, Clatot F, Vinches M, Iacob M, Martin L, Kaminsky MC, Vansteene D, Salas S, Champagnac A, Saintigny P, Gautier J, Pérol D, Bourhis J.   +18 more
europepmc   +1 more source

Venous Thromboembolism in Women with Breast and Gynaecological Cancers: What Do We Know and What Should We Do? [PDF]

Clin Appl Thromb Hemost
Poenou G, Corbaux P, Accassat S, Chauleur C, Bertoletti L.   +4 more
europepmc   +1 more source